AP Wire | 11/13/2004 | Police say child got drugs from breast milk
Associated Press
"FORT WORTH, Texas - A mother of six has been indicted on a charge of recklessly causing serious bodily injury to a child by passing drug-tainted breast milk to her 14-month-old daughter. 'I think a Tarrant County jury will probably be outraged by this and will be glad to have a chance to litigate it,' prosecutor Mitch Poe told the Fort Worth Star-Telegram for its Saturday editions. 'Hopefully, this will send a strong message to nursing mothers to stop doing drugs.'Corrina Annette Richardson, 35, remained in the Tarrant County Jail on Saturday morning with bail set at $10,000. She was indicted Wednesday...."
Saturday, November 13, 2004
Friday, November 12, 2004
Martek Receives Adverse Ruling on European DHA/ARA Oil Blends Patent; Validity of Patent Will Be Unaffected During Appeal Process
Martek Receives Adverse Ruling on European DHA/ARA Oil Blends Patent; Validity of Patent Will Be Unaffected During Appeal Process
Friday November 12, 7:56 am ET
"COLUMBIA, Md., Nov. 12 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK - News) today announced that its European DHA/ARA Oil Blends Patent was revoked in a proceeding that was held in Munich, Germany by the European Patent Office on November 11, 2004. The hearing was the result of challenges made by two potential competitors of the Company. The Company intends, within the next few days, to file an appeal that will automatically reinstate the patent so that it will remain in force during the appeal process. The appeal process is anticipated to exceed two years. The Company believes that it has substantive grounds for the appeal and intends to vigorously pursue the matter...."
Martek Receives Adverse Ruling on European DHA/ARA Oil Blends Patent; Validity of Patent Will Be Unaffected During Appeal Process
Friday November 12, 7:56 am ET
"COLUMBIA, Md., Nov. 12 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK - News) today announced that its European DHA/ARA Oil Blends Patent was revoked in a proceeding that was held in Munich, Germany by the European Patent Office on November 11, 2004. The hearing was the result of challenges made by two potential competitors of the Company. The Company intends, within the next few days, to file an appeal that will automatically reinstate the patent so that it will remain in force during the appeal process. The appeal process is anticipated to exceed two years. The Company believes that it has substantive grounds for the appeal and intends to vigorously pursue the matter...."
Thursday, November 11, 2004
Nestle Launches NESTLE(R) GOOD START(R) Supreme Soy DHA & ARA
Thursday November 11, 1:08 pm ET
"GLENDALE, Calif., Nov. 11 /PRNewswire/ -- As soy products continue to move more mainstream in the diet of Americans, Nestle USA, part of Nestle S.A., a world leader in infant nutrition, announces the national launch of a soy version of the popular infant formula NESTLE GOOD START Supreme DHA & ARA. Though experts agree breastmilk is best, moms who cannot or choose not to breastfeed will be comforted to know that now there is complete iron-fortified nutrition in a milk-free, lactose-free formula that uniquely combines both Supreme Soy Proteins specially designed to be easy-to-digest and DHA& ARA for healthy brain and eye development...."
Thursday November 11, 1:08 pm ET
"GLENDALE, Calif., Nov. 11 /PRNewswire/ -- As soy products continue to move more mainstream in the diet of Americans, Nestle USA, part of Nestle S.A., a world leader in infant nutrition, announces the national launch of a soy version of the popular infant formula NESTLE GOOD START Supreme DHA & ARA. Though experts agree breastmilk is best, moms who cannot or choose not to breastfeed will be comforted to know that now there is complete iron-fortified nutrition in a milk-free, lactose-free formula that uniquely combines both Supreme Soy Proteins specially designed to be easy-to-digest and DHA& ARA for healthy brain and eye development...."
Monday, November 08, 2004
Edinburgh Student Newspaper : News : Deceit and malpractice at Nestlé debate
Deceit and malpractice at Nestlé debate
"With the ‘Freedom of Choice’ motion due to be voted on at the AGM this Wednesday, representatives from Nestlé and Baby Milk Action came together last week to debate, argue and accuse. Nestlé is one of the world’s largest multinational food companies, with an annual turnover of £39 billion, and the largest share of the baby food market. Baby Milk Action is the United Kingdom member of the International Baby Food Action Network (IBFAN), a pressure group formed to fight against “baby food marketing malpractice.”
Debate
The debate took place on Wednesday in the David Hume Tower with Hilary Parsons, Head of Corporate Affairs of Nestlé UK, and Mike Brady, Baby Milk Action’s Campaigns and Network Coordinator, representing the two camps. There is currently a boycott in all EUSA venues on Nestlé products, yet this could be repealed on Wednesday if there is enough favourable student support. The central issue concerns Nestlé’s ‘aggressive marketing’ of its breast milk substitutes in the developing world...."
Deceit and malpractice at Nestlé debate
"With the ‘Freedom of Choice’ motion due to be voted on at the AGM this Wednesday, representatives from Nestlé and Baby Milk Action came together last week to debate, argue and accuse. Nestlé is one of the world’s largest multinational food companies, with an annual turnover of £39 billion, and the largest share of the baby food market. Baby Milk Action is the United Kingdom member of the International Baby Food Action Network (IBFAN), a pressure group formed to fight against “baby food marketing malpractice.”
Debate
The debate took place on Wednesday in the David Hume Tower with Hilary Parsons, Head of Corporate Affairs of Nestlé UK, and Mike Brady, Baby Milk Action’s Campaigns and Network Coordinator, representing the two camps. There is currently a boycott in all EUSA venues on Nestlé products, yet this could be repealed on Wednesday if there is enough favourable student support. The central issue concerns Nestlé’s ‘aggressive marketing’ of its breast milk substitutes in the developing world...."
Subscribe to:
Posts (Atom)